Search Results 1691-1700 of 3954 for Solid

  1. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

    - Has had an allogenic tissue/solid organ transplant. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 1/5/23 ...

  2. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

    Subject must have at least one measurable target lesion as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v.1.1. Melanoma subjects ...

  3. Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304) - Mayo Clinic

    Has had an allogenic tissue/solid organ transplant. Has ongoing sensory or motor neuropathy Grade 2 or higher. Has active keratitis (superficial punctate ...

  4. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

    Presence of measurable lesions (as per Response Evaluation Criteria in Solid Tumors [RECIST]1.1); generally a ≥ 10 mm tumor lesion (in the longest diameter ...

  5. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

    Patients who have had allogeneic SCT/solid organ transplant. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  6. Pyridorin In Diabetic Nephropathy - Clinical Trials

    Patients with a history of solid organ transplantation; Patients with a history of myocardial infarction, coronary re-vascularization procedures (including ...

  7. Pulmonary Medicine Clinical Trials - Medical Professionals

    ... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Safety and Durability of Sirolimus for Treatment of LAM. Rochester, Minn., Jacksonville, Fla ...

  8. Pulmonary Medicine Clinical Trials - Medical Professionals

    ... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Safety and Durability of Sirolimus for Treatment of LAM. Rochester, Minn., Jacksonville, Fla ...

  9. A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared with Placebo for the Treatment of Participants with Mycobacterium Avium Complex (MAC) Pulmonary Disease - Mayo Clinic

    solid agar 4. Is either treatment naïve and has not received any prior treatment for MAC, OR if previously treated for MAC and meets all of the following ...

  10. A Study to Evaluate Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

    - Kidney or any other solid organ transplant recipient or a planned transplant during the study; - Acute dialysis or acute kidney injury within 12 weeks ...